May 24, 2018
While multi-drug combination therapies for HIV has resulted in longer lifespans, simplified medication regimens are needed to reduce pill-burden in an aging population with HIV. Two-drug regimens are potentially attractive because they may minimize drug exposure; reduce risks for adverse effects, drug-drug interactions, and long-term toxicities; and potentially increase patient adherence. The SWORD-1 and SWORD-2 trials evaluated the efficacy and safety of a two-drug regimen to maintain viral suppression in HIV infected patients.
Guest Authors Tinh An (April) Nguyen, PharmD and Jihae Lim, PharmD
Music by Good Talk
April 27, 2018
Overuse of broad-spectrum antibiotics can lead to antimicrobial resistance, increased cost, and higher prevalence of adverse drug reactions. Nearly 2 million infections and 23,000 deaths are caused by bacteria that are antibiotic-resistant each year in the United States costing the healthcare system an estimated 20 billion dollars. Moreover, adverse reactions to antibiotics are the most common reason for pediatric patients to visit the emergency department. Narrow-spectrum antimicrobials are generally preferred, but there are instances where broader coverage is recommended. A recent study attempts to “clean up” the debate by examining the benefits and risks of using narrow- versus broad-spectrum antibiotics in children with acute respiratory tract infections.
Guest Authors: Amber Giles, PharmD, MPH, BCPS, AAHIVP and Paige Hughes, PharmD
Music by Good Talk
June 26, 2017
Observational studies and systematic reviews have shown an association between low vitamin D concentrations and acute respiratory tract infections (ARTIs). An association is one thing, but can vitamin D supplementation reduce the risk of ARTIs? That’s what a recent systematic review and meta-analysis attempted to determine.
Guest Author: Amanda Schartel, Pharm.D., BCACP
Theme music by Good Talk